Suppr超能文献

自身免疫性慢性活动性肝炎中的抗原特异性抑制细胞功能

Antigen specific suppressor cell function in autoimmune chronic active hepatitis.

作者信息

Vento S, Hegarty J E, Bottazzo G, Macchia E, Williams R, Eddleston A L

出版信息

Lancet. 1984 Jun 2;1(8388):1200-4. doi: 10.1016/s0140-6736(84)91691-x.

Abstract

An indirect migration inhibition assay has been used to show that lymphocytes from 26 of 29 patients with autoimmune chronic active hepatitis (CAH) generated T lymphocyte migration inhibitory factors (T-LIF) in the presence of liver specific protein (LSP), compared with only 1 of 21 patients with HBsAg-positive chronic liver disease and none of 19 controls. Generation of T-LIF activity in response to LSP was not observed in any of 5 patients with autoimmune thyroid disease although their T lymphocytes did generate T-LIF activity in the presence of thyroid membrane antigens. T lymphocytes from 1 patient with autoimmune liver and thyroid disease generated T-LIF activity in the presence of both LSP and thyroid membrane antigens. The generation of T-LIF activity by T cells from autoimmune CAH patients was suppressed when these cells were co-cultured in a 9:1 ratio with T cells from normal subjects and patients with HBsAg-positive chronic liver disease, but was unaffected if co-cultured with T cells from other patients with autoimmune CAH. T cells from patients with autoimmune CAH did, however, suppress the generation of T-LIF activity by T lymphocytes from patients with autoimmune thyroid disease when these cells were cultured with thyroid membrane antigens. After pretreatment with cimetidine or mitomycin-C for 30 min, T cells from normal subjects lost their ability to inhibit the generation of T-LIF activity to T lymphocytes from autoimmune CAH patients. These results are consistent with the hypothesis that there exists a defect in the specific suppressor T cell population controlling the immune response to LSP in autoimmune CAH which is unaffected by disease activity and treatment and which may be of fundamental importance in the pathogenesis of the disease.

摘要

已采用间接迁移抑制试验表明,29例自身免疫性慢性活动性肝炎(CAH)患者中有26例的淋巴细胞在肝特异性蛋白(LSP)存在的情况下产生T淋巴细胞迁移抑制因子(T-LIF),相比之下,21例HBsAg阳性慢性肝病患者中只有1例产生T-LIF,而19例对照中无人产生。5例自身免疫性甲状腺疾病患者中,尽管其T淋巴细胞在甲状腺膜抗原存在时确实产生T-LIF活性,但在任何患者中均未观察到对LSP产生T-LIF活性。1例自身免疫性肝病和甲状腺疾病患者的T淋巴细胞在LSP和甲状腺膜抗原两者存在时均产生T-LIF活性。当自身免疫性CAH患者的T细胞与正常受试者和HBsAg阳性慢性肝病患者的T细胞以9:1的比例共培养时,这些T细胞产生T-LIF活性受到抑制,但与其他自身免疫性CAH患者的T细胞共培养时则不受影响。然而,当自身免疫性CAH患者的T细胞与自身免疫性甲状腺疾病患者的T淋巴细胞在甲状腺膜抗原存在的情况下培养时,前者确实会抑制后者产生T-LIF活性。在用西咪替丁或丝裂霉素-C预处理30分钟后,正常受试者的T细胞失去了抑制自身免疫性CAH患者T淋巴细胞产生T-LIF活性的能力。这些结果与以下假设一致:在自身免疫性CAH中,存在控制对LSP免疫反应的特异性抑制性T细胞群体缺陷,该缺陷不受疾病活动和治疗的影响,且可能在该疾病的发病机制中具有根本重要性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验